Gyno-Pevaryl
Gyno-Pevaryl Brand names, Gyno-Pevaryl Analogs
Gyno-Pevaryl Brand Names Mixture
- No information avaliable
Gyno-Pevaryl Chemical_Formula
C12H15N5O3
Gyno-Pevaryl RX_link
http://www.rxlist.com/cgi/generic4/baraclude.htm
Gyno-Pevaryl fda sheet
Gyno-Pevaryl msds (material safety sheet)
Gyno-Pevaryl Synthesis Reference
No information avaliable
Gyno-Pevaryl Molecular Weight
277.279 g/mol
Gyno-Pevaryl Melting Point
No information avaliable
Gyno-Pevaryl H2O Solubility
Slightly soluble (2.4 mg/mL at pH 7.9, 25oC)
Gyno-Pevaryl State
Solid
Gyno-Pevaryl LogP
No information avaliable
Gyno-Pevaryl Dosage Forms
Film-coated tablets for oral administration (0.5 mg, 1 mg); Oral solution (0.05 mg/mL)
Gyno-Pevaryl Indication
For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Gyno-Pevaryl Pharmacology
Entecavir is a guanosine nucleoside analogue with selective activity against hepatitis B virus (HBV). It is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process. Entecavir is more efficient than an older Hepatitis B drug, lamivudine.
Gyno-Pevaryl Absorption
Absorption Following oral administration in healthy subjects, entecavir peak plasma concentrations occurred between 0.5 and 1.5 hours. In healthy subjects, the bioavailability of the tablet is 100% relative to the oral solution.
Gyno-Pevaryl side effects and Toxicity
No information avaliable
Gyno-Pevaryl Patient Information
Gyno-Pevaryl Organisms Affected
Hepatitis B
